Acute central nervous system complications in varicella zoster virus infections

Journal of Clinical Virology

Volumn 25, Issue 3, 2002, Pages 293-301

  Koskiniemi, Marjaleena ^a,b   Piiparinen, Heli ^b   Rantalaiho, Timo ^a   Eränkö, Pekka ^c   Färkkilä, Markus ^b   Räihä, Kirsti ^b   Salonen, Eeva Marjatta ^b   Ukkonen, Pentti ^b   Vaheri, Antti ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Glaxo Wellcome Pharmaceutical Company   (Finland)

Author keywords

Central nervous system; Chickenpox; Shingles; Varicella zoster virus; Zoster

Indexed keywords

IMMUNOGLOBULIN M; NUCLEIC ACID;

ACUTE DISEASE; AGE; ANTIBODY PRODUCTION; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD ANALYSIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID EXAMINATION; CHICKENPOX; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENDER; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RASH; SAMPLING; SENSITIVITY AND SPECIFICITY; SKIN MANIFESTATION; TREATMENT INDICATION; VARICELLA ZOSTER VIRUS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CHICKENPOX; CHILD; DNA, VIRAL; ENCEPHALITIS, VARICELLA ZOSTER; FEMALE; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SKIN DISEASES;

EID: 0036888271     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00020-3     Document Type: Article

References (31)

1. Amlie-Lefond C., Kleinschmidt-DeMasters B.K., Mahalingam R., Davis L.E., Gilden D.H. The vasculopathy of varicella-zoster virus encephalitis. Ann. Neurol. 37:1995;784-790.
2. Appelbaum E., Rachelson M.H., Dolgopol V.B. Varicella encephalitis. Am. J. Med. 5:1953;223-230.
3. Bale J.F. Viral encephalitis. Med. Clin. North Am. 77:1993;25-42.
4. Beghi E., Nicolosi A., Kurland L.T., et al. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology. Ann. Neurol. 6:1984;283-294.
5. Bergström T. Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations. Scand. J. Infect. Dis. Suppl. 100:1995;41-45.
6. Echevarria J.M., Casas I., Tenorio A., et al. Detection of varicella-zoster virus-specific DNA sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions. J. Med. Virol. 43:1994;331-335.
7. Echevarria J.M., Casas I., Martinez-Martin P. Infections of the nervous system caused by varicella-zoster virus: a review. Intervirology. 40:1997;72-84.
8. Fleisher G., Henry W., McSorley M., et al. Life threatening complications of varicella. Am. J. Dis. Child. 135:1981;896-899.
9. Gershon A., Steinberg S., Greenberg S., Taber L. Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J. Clin. Microbiol. 12:1980;764-767.
10. Gilden D.H., Beinlich B.R., Rubinstein E.M., et al. Varicella-zoster virus myelitis; an expanding spectrum. Neurology. 44:1994;1818-1823.
11. Gilden D.H., Wright R.R., Schneck S.A., et al. Zoster sine herpete, a clinical variant. Ann. Neurol. 35:1994b;530-533.
12. Gilden D.H., Kleinschmidt-DeMasters B.K., Wellish M., et al. Varicella-zoster virus, a cause of waxing and waning vasculitis. Neurology. 47:1996;1441-1446. The New England Journal of Medicine case 5-1995 revisited.
13. Gilden D.H., Bennett J.L., Kleinschmidt-DeMasters B.K., et al. The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella-zoster virus. J. Neurol. Sci. 59:1998;140-144.
14. Gilden D.H., Kleinschmidt-DeMasters B.K., LaGuardia J.J., et al. Neurologic complications of the reactivation of varicella-zoster virus. New Engl. J. Med. 342:2000;635-645.
15. Heisler M.B., Richmond J.B. Lessons from Finlands successful immunization program. New Engl. J. Med. 331:1994;1446-1447.
16. Horten B., Price R.W., Jimenez D. Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann. Neurol. 9:1981;251-266.
17. Jemsek J., Greenberg S.B., Taber L., et al. Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore). 62:1983;81-97.
18. Koskiniemi M., Vaheri A. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet. 1:1989;31-34.
19. Koskiniemi M., Rautonen J., Lehtokoski-Lehtiniemi E., Vaheri A. Epidemiology of encephalitis in children: a 20-year survey. Ann. Neurol. 29:1991;492-497.
20. Koskiniemi M., Mannonnen L., Kallio A., Vaheri A. Luminometric microplate hybridization for detection of Varicella-zoster virus PCR product from cerebrospinal fluid. J. Virol. Methods. 63:1997;71-79.
21. Koskiniemi M., Rantalaiho T., Piiparinen H., et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J. Neurovirol. 7:2001;400-408.
22. Law B., MacDonald N., Jalpern S., et al. The immunization monitoring program active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or associated complications. Pediatr. Infect. Dis. J. 19:2000;053-1059.
23. Meszner Z., Nyerges G., Bell A.R. Oral acyclovir to prevent dissemination of varicella in immunocomprimised children. J. Infect. 26:1993;9-15.
24. Peltola H., Heinonen O.P., Valle M., et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. New Engl. J. Med. 31:1994;1397-1402.
25. Piiparinen H., Vaheri A. Genotyping of herpes viruses by polymerase chain reaction. Arch. Virol. 119:1991;275-283.
26. Preblud S.R., Orenstein W.A., Bart K.J. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr. Infect. Dis. J. 3:1984;505-509.
27. Puchhammer E., Popow-Kraupp T., Heinz F., et al. Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J. Clin. Microbiol. 29:1991;1513-1516.
28. Sundqvist V.A. Frequency and specificity of varicella zoster virus IgM response. J. Virol. Methods. 5:1982;219-227.
29. Weller T.H. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a Not-So-Benign virus (second of two parts). New Engl. J. Med. 309:1983;1362-1368.
30. Whitley R.J. Therapeutic approaches to varicella-zoster virus infections. J. Infect. Dis. 166:(Suppl. 1):1992;551-557.
31. Wood M.J., Johnson R.W., McKendrick M.W., et al. A randomized trial of acyclovir for 7 or 21 days with and without prednisolone for treatment of acute herpes zoster. New Engl. J. Med. 330:1994;896-900.